On February 23, 1954, the first large-scale trial of the polio vaccine
developed by Dr. Jonas Salk began in Pittsburgh, Pennsylvania. The trial
involved nearly 2 million children, known as the "Polio Pioneers," who
received the vaccine. This marked a significant step in the fight
against polio, a debilitating and potentially deadly disease that had
caused widespread fear and epidemics. The success of the trial
eventually led to the widespread use of the Salk vaccine, which played a
crucial role in the near-eradication of polio in many parts of the
world.
No comments:
Post a Comment